Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses

Cell

Volumn 93, Issue 5, 1998, Pages 841-850

  Teglund, Stephan ^a   McKay, Catriona ^a   Schuetz, Erin ^a   Van Deursen, Jan M ^a   Stravopodis, Dimitrios ^a   Wang, Demin ^a   Brown, Michael ^a   Bodner, Sara ^a   Grosveld, Gerard ^a   Ihle, James N ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; PROTEIN TYROSINE KINASE;

ARTICLE; ENZYME ACTIVATION; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

JANUS; RODENTIA;

EID: 0000943469     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81444-0     Document Type: Article

References (62)

1. Angerer, L.M., and Angerer, R.C. (1992). In situ hybridization to cellular RNA with radiolabelled RNA probes. In In Situ Hybridization: A Practical Approach, D.G. Wilkinson, ed. (Oxford: Oxford University Press), pp. 15-32.
2. Chretien, S., Varlet, P., Verdier, F., Gobert, S., Cartron, J.-P., Gisselbrecht, S., Mayeux, P., and Lacombe, C. (1996). Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired stat5 activation. EMBO J. 15, 4174-4181.
3. Copeland, N.G., Gilbert, D.J., Schindler, C., Zhong, Z., Wen, Z., Darnell, J.E., Jr., Mui, A.-F., Miyajima, A., Quelle, F.W., Ihle, J.N., and Jenkins, N.A. (1995). Distribution of the mammalian Stat gene family in mouse chromosomes. Genomics 29, 225-228.
4. Damen, J.E., Wakao, H., Miyajima, A., Krosl, J., Humphries, R.K., Cutler, R.L., and Krystal, G. (1995). Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 14, 5557-5568.
5. Darnell, J.E.J. (1997). STATs and gene regulation. Science 277, 1630-1635.
6. Darnell, J.E., Jr., Kerr, I.M., and Stark, G.R. (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
7. Donahue, L.R., and Beamer, W.G. (1993). Growth hormone deficiency in "little" mice results in aberrant body composition, reduced insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. J. Endocrinol. 136, 91-104.
8. Durbin, J.E., Hackenmiller, R., Simon, M.C., and Levy, D.E. (1996). Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450.
9. Fero, M.L., Rivkin, M., Tasch, M., Porter, P., Carow, C.E., Firpo, E., Polyak, K., Tsai, L.H., Broudy, V., Perlmutter, R.M., Kaushansky, K., and Roberts, J.M. (1996). A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85, 733-744.
10. Gobert, S., Porteu, F., Pallu, S., Muller, O., Sabbah, M., Dusanter-Fourt, I., Courtois, G., Lacombe, C., Gisselbrecht, S., and Mayeux, P. (1995). Tyrosine phosphorylation of the erythropoietin receptor: role for differentiation and mitogenic signal transduction. Blood 86, 598-606.
11. Gobert, S., Chretien, S., Gouilleux, F., Muller, O., Pallard, C., Dusanter-Fourt, I., Groner, B., Lacombe, C., Gisselbrecht, S., and Mayeux, P. (1996). Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO J. 15, 2434-2441.
12. Gouilleux, F., Pallard, C., Dusanter-Fourt, I., Wakao, H., Haldosen, L.A., Norstedt, G., Levy, D., and Groner, B. (1995). Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J. 14, 2005-2013.
13. Hogan, B., Beddington, R., Costantini, F., and Lacy, E. (1994). Manipulating the Mouse Embryo: A Laboratory Manual, Second Edition (Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press).
14. Horseman, N.D., Zhao, W., Montecino-Rodriguez, E., Tanaka, M., Nakashima, K., Engle, S.J., Smith, F., Markoff, E., and Dorshkind, K. (1997). Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO. J. 16, 6926-6935.
15. Hou, J., Schindler, U., Henzel, W.J., Wong, S.C., and McKnight, S.L. (1995). Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity 2, 321-329.
16. Ihle, J.N. (1995a). Cytokine receptorsignalling. Nature 377, 591-594.
17. Ihle, J.N. (1995b). The Janus protein tyrosine kinase family and its role in cytokine signaling. Adv. Immunol. 60, 1-35.
18. Ihle, J.N. (1996). STATs: signal tranducers and activators of transcription. Cell 84, 331-334.
19. Ilaria, R.L.J., and Van Etten, R.A. (1996). P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J. Biol. Chem. 277, 31704-31710.
20. Iwatsuki, K., Endo, T., Misawa, H., Yokouchi, M., Matsumoto, A., Ohtsubo, M., Mori, K.J., and Yoshimura, A. (1997). STAT5 activation correlates with erythropoietin receptor-mediated erythroid differentiation of an erythroleukemia cell line. J. Biol. Chem. 272, 8149-8152.
21. Kaplan, M.H., Schindler, U., Smiley, ST., and Grusby, M.J. (1996a). State is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4, 313-319.
22. Kaplan, M.H., Sun, Y.-L, Hoey, T., and Grusby, M.J. (1996b). Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174-177.
23. Kiyokawa, H., Kineman, R.D., Manova-Todorova, K.O., Soares, V.C., Hoffman, E.S., Ono, M., Khanam, D., Hayday, A.C., Frohman, L.A., and Koff, A. (1996). Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85, 721-732.
24. Liu, X., Robinson, G.W., Gouilleux, F., Groner, B., and Hennighausen, L. (1995). Cloning and expression of stat5 and an additional homologue (stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc. Natl. Acad. Sci. USA 92, 8831-8835.
25. Liu, X., Robinson, G.W., Wagner, K.U., Garrett, L., Wynshaw-Boris, A., and Hennighausen, L. (1997). Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11, 179-186.
26. Lydon, J.P., DeMayo, F.J., Funk, C.R., Mani, S.K., Hughes, A.R., Montgomery, C.A.J., Shyamala, G., Conneely, O.M., and O'Malley, B.W. (1995). Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9, 2266-2278.
27. Meraz, M.A., White, J.M., Sheehan, K.C.F., Bach, E.A., Rodig, S.J., Dighe, A.S., Kaplan, D.H., Riley, J.K., Greenlund, A.C., Campbell, D., et al. (1996). Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442.
28. Migone, T.-S., Lin, J.-X., Cereseto, A., Mulloy, J.C., O'Shea, J.J., Franchini, G., and Leonard, W.J. (1995). Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-1. Science 269, 79-81.
29. Mui, A.-F., Wakao, H., Kinoshita, T., Kitamura, T., and Miyajima, A. (1996). Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J. 15, 2425-2433.
30. Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., and Loh, D.Y. (1996). Mice lacking p27(Kip1)display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707-720.
31. Nishinakamura, R., Miyajima, A., Mee, P.J., Tybulewicz, V.L.J., and Murray, R. (1996). Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions. Blood 88, 2458-2464.
32. Norstedt, G., and Palmiter, R. (1984). Secretory rhythm of growth hormone regulates sexual differentiation of mouse liver. Cell 36, 805-812.
33. Ogawa, S., Kurokawa, M.A.T.T., Mitani, K.K.K., Inazawa, J., Hangaishi, A., Tanaka, K., Matsuo, Y., Minowada, J., Tsubota, T., Yazaki, Y., and Hirai, H. (1996). Structurally altered Evi-1 protein generated in the 3q21q26 syndrome. Oncogene 13, 183-191.
34. Ormandy, C.J., Camus, A., Barra, J., Damotte, D., Lucas, B., Buteau, H., Edery, M., Brousse, N., Babinet, C., Binart, N., and Kelly, P.A. (1997). Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11, 167-178.
35. Pallard, C., Gouilleux, F., Benit, L., Cocault, L., Souyri, M., Levy, D., Groner, B., Gisselbrecht, S., and Dusanter-Fourt, I. (1995). Thromopoietin activates a STAT5-like factor in hematopoietic cells. EMBO J. 14, 2847-2856.
36. Parganas, E., Wang, D., Stravopodis, D., Topham, D.J., Marine, J.-C., Teglund, S., Vanin, E.F., Bodner, S., Colamonici, O.R., van Deursen, J. M., Grosveld, G., and Ihle, J.N. (1998). Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93, 385-395.
37. Parmer, T.G., Roberts, C.T.J., LeRoith, D., Adashi, E.Y., Khan, I., Solan, N., Nelson, S., Zilberstein, M., and Gibori, G. (1991). Expression, action, and steroidal regulation of insulin-like growth factor-I (IGF-I) and IGF-I receptor in the rat corpus luteum: their differential role in the two cell populations forming the corpus luteum. Endocrinology 129, 2924-2932.
38. Quelle, F.W., Shimoda, K., Thierfelder, W., Fischer, C., Kim, A., Ruben, S.M., Cleveland, J.L., Pierce, J.H., Keegan, A.D., Nelms, K., Paul, W.E., and Ihle, J.N. (1995). Cloning of murine State and human Stat6, stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 15, 3336-3343.
39. Quelle, F.W., Wang, D., Nosaka, T., Thierfelder, W.E., Stravopodis, D., Weinstein, Y., and Ihle, J.N. (1996). Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol. 16, 1622-1631.
40. Ripperger, J.A., Fritz, S., Richter, K., Hocke, G.M., Lottspeich, F., and Fey, G.H. (1995). Transcription factors Stat3 and Stat5b are present in rat liver nuclei late in an acute phase response and bind interleukin-6 response elements. J. Biol. Chem. 270, 29998-30006.
41. Shimoda, K., van Deursen, J., Sangster, M.Y., Sarawar, S.R., Carson, R.T., Tripp, R.A., Chu, C., Quelle, F.W., Nosaka, T., Vignali, D.A.A., et al. (1996). Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State gene. Nature 380, 630-633.
42. Shuai, K., Halpern, J., ten Hoeve, J., Rao, X., and Sawyers, C.L. (1996). Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13, 247-254.
43. Sicinski, P., Donaher, J.L., Geng, Y., Parker, S.B., Gardner, H., Park, M.Y., Robker, R.L., Richards, J.S., McGinnis, L.K., Biggers, J.D., et al. (1996). Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384, 470-474.
44. Squires, E.J., and Negishi, M. (1988). Reciprocal regulation of sex-dependent expression of testosterone 15 alpha-hydroxylase (P-450(15 alpha)) in liver and kidney of male mice by androgen: evidence for a single gene. J. Biol. Chem. 263, 4166-4171.
45. Suzuki, H., Kundig, T.M., Furlonger, C., Wakeham, A., Timms, E., Matsuyama, T., Schmits, R., Simard, J.J.L., Ohashi, P.S., Griesser, H., Taniguchi, T., Paige, C.J., and Mak, T.W. (1995). Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268, 1472-1476.
46. Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., and Akira, S. (1997). Targeted disruption of the mouse stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 94, 3801-3804.
47. Thierfelder, W.E., van Deursen, J., Yamamoto, K., Tripp, R.A., Sarawar, S.R., Carson, R.T., Sangster, M.Y., Vignali, D.A.A., Doherty, P.C., Grosveld, G., and Ihle, J.N. (1996). Stat4 is required for IL-12 mediated responses of NK and T-cells. Nature 382, 171-174.
48. Tian, S.-S., Lamb, P., Seidel, H.M., Stein, R.B., and Rosen, J. (1994). Rapid activation of the Stat3 transcription factor by granulocyte colony-stimulating factor. Blood 84, 1760-1764.
49. Tweardy, D.J., Wright, T.M., Ziegler, S.F., Baumann, H., Chakraborty, A., White, S.M., Dyer, K.F., and Rubin, K.A. (1995). Granulocyte colony-stimulating factor rapidly activates a distinct STAT-like protein in normal myeloid cells. Blood 86, 4409-4416.
50. Udy, G.B., Snell, R.G., Wilkins, R.J., Park, S.-H., Ram, P.A., Waxman, D.J., and Davey, H.W. (1997). Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 94, 7239-7244.
51. van Deursen, J., Lovell-Badge, R., Oerlemans, F., Schepens, J., and Wieringa, B. (1991). Modulation of gene activity by consecutive gene targeting of one creatine kinase M allele in mouse embryonic stem cells. Nucleic Acids Res. 19, 2637-2643.
52. van Deursen, J., Heerschap, A., Oerlemans, F., Ruitenbeek, W., Jap, P., ter Laak, H., and Wieringa, B. (1993). Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity. Cell 74, 621-631.
53. Wakao, H., Gouilleux, F., and Groner, B. (1994). Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J. 13, 2182-2191.
54. Wakao, H., Harada, N., Kitamura, T., Mui, A.L.F., and Miyajima, A. (1995). Interleukin 2 and erthropoietin activate STAT5/MGF via distinct pathways. EMBO J. 14, 2527-2535.
55. Wakao, H., Chida, D., Damen, J.E., Krystal, G., and Miyajima, A. (1997). A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis. Biochem. Biophys. Res. Commun. 234, 198-205.
56. Wang, D., Stravopodis, D., Teglund, S., Kitazawa, J., and Ihle, J.N. (1996). Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol. 16, 6141-6148.
57. Woldman, I., Mellitzer, G., Kieslinger, M., Buchhart, D., Meinke, A., Beug, H., and Decker, T. (1997). STAT5 involvement in the differentiation response of primary chicken myeloid progenitor cells to chicken myelomonocytic growth factor. J. Immunol. 159, 877-886.
58. Wood, T.J., Silva, D., Lobie, P.E., Pircher, T.J., Gouilleux, F., Wakao, H., Gustafsson, J.A., Groner, B., Norstedt, G., and Haldosen, L.A. (1995). Mediation of growth hormone-dependent transcriptional activation by mammary gland factor/Stat 5. J. Biol. Chem. 270, 9448-9453.
59. Yamauchi, T., Ueki, K., Tobe, K., Tamemoto, H., Sekine, N., Wada, M., Honjo, M., Takahashi, M., Takahashi, T., Hirai, H., et al. (1997). Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 390, 91-96.
60. Yoshimura, A., Ichihara, M., Kinjyo, I., Moriyama, M., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Hara, T., and Miyajima, A. (1996). Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO J. 15, 1055-1063.
61. Zhong, L., Farmer, T.G., Robertson, M.C., and Gibori, G. (1997). Prolactin-mediated inhibition of 20alpha-hydroxysteroid dehydrogenase gene expression and the tyrosine kinase system. Biochem. Biophys. Res. Commun. 235, 587-592.
62. Zhou, Y., Xu, B.C., Maheshwari, H.G., He. L., Reed. M., Lozykowski, M., Okada, S., Cataldo, L., Coschigamo, K., Wagner, T.E., Baumann, G., and Kopchick, J.J. (1997). A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc. Natl. Acad. Sci. USA 94, 13215-13220.